Effects of Exercise Training in Survivors of Lymphoma
Launched by NORWEGIAN SCHOOL OF SPORT SCIENCES · Feb 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of exercise can help people who have survived lymphoma, particularly those who received a specific type of chemotherapy called anthracyclines. Researchers want to see if aerobic exercise (like running or swimming) alone or combined with resistance training (like lifting weights) can improve health compared to those who don’t have a history of cancer. They are looking for participants who have completed their lymphoma treatment within the last two to five years and are not experiencing severe fatigue.
To join the study, participants need to be between 18 and 75 years old, have a confirmed lymphoma diagnosis, and not be currently active in more than 75 minutes of aerobic exercise per week. Those who are eligible can expect to engage in a structured exercise program and monitor their health alongside a supportive team. It's important to note that individuals with a history of cancer relapse, certain heart conditions, or those unable to understand the study procedures in Swedish or Norwegian are not eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria Lymphoma participants:
- • Listed in relevant registers
- • Confirmed lymphoma diagnosis (i.e., Hodgkin lymphoma and aggressive non-Hodgkin lymphoma)
- • Completed treatment in the past two to five years without relapse or second cancer
- • Previous anthracycline treatment with or without mediastinal radiation
- • No severe cancer-related fatigue (per self-report)
- Inclusion Criteria Lymphoma participants and non-cancer reference group:
- • Currently not performing \>75 minutes/week of aerobic exercise
- • Willing and able to adhere to all study procedures.
- Exclusion Criteria Lymphoma participants:
- • Relapse since diagnosis
- • A history, or current presence, of another diagnosis of invasive cancer of any kind
- Exclusion Criteria Lymphoma participants and non-cancer reference group:
- • Presence of any uncontrolled- or recent cardiovascular disease
- • Has undergone heart surgery
- • Uses a pacemaker
- • Pregnancy
- • Unable to read and understand Swedish (applicable for the Swedish site only)
- • Unable to read and understand Norwegian (applicable for the Norwegian site)
- • Any physical or mental health condition restricting adherence to study protocol
About Norwegian School Of Sport Sciences
The Norwegian School of Sport Sciences (NIH) is a leading research institution dedicated to advancing knowledge in the fields of sport, exercise, and health. With a strong emphasis on interdisciplinary collaboration, NIH conducts innovative clinical trials aimed at enhancing athletic performance, improving public health, and understanding the physiological and psychological impacts of physical activity. The institution is committed to fostering a rigorous scientific environment, promoting evidence-based practices, and contributing to the global discourse on sports science through high-quality research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Uppsala, , Sweden
Patients applied
Trial Officials
Tormod S. Nilsen, PhD
Principal Investigator
Norwegian School of Sport Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported